About Labseed
Labseed is a company based in Lausanne (Switzerland) founded in 2009. Labseed has raised $115.35 thousand across 1 funding round from investors including Venture Kick. Labseed offers products and services including MYcoatâ„¢. Labseed operates in a competitive market with competitors including SetPoint Medical, Boomerang Medical, Hippo Dx, Therakos and Soteria Medical, among others.
- Headquarter Lausanne, Switzerland
- SectorsHealthcare
- Website labseed.ch
- Total Equity Funding$115.35K (USD)
in 1 rounds
- Latest Funding Round$115.35K (USD), Seed
Jun 2018
- Investors
Products & Services of Labseed
Labseed offers a comprehensive portfolio of products and services, including MYcoat™.
Coating that prevents fibrotic reactions in medical implants
Funding Insights of Labseed
Labseed has successfully raised a total of $115.35K through 1 strategic funding round. The most recent funding activity was a Seed round of $115.35 thousand completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $115,346
- Total Rounds 1
- Last Round Seed — $115,346
- First Round $115,346
(Jun 2018)
- Investors Count 1
All 1 funding rounds of Labseed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2018 | $115,346 | Seed | – | Venture Kick | – |
1 investors in total: 1 institutional.
Investors in Labseed
Labseed has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
University backed startup accelerator | – | venturekick.ch | Schlieren, Switzerland |
Investor details for Labseed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Labseed
2 dated milestones of Labseed across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Labseed is founded.
- Funding First funding round of $115K.
Competitors of Labseed
Labseed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SetPoint Medical, Boomerang Medical, Hippo Dx, Therakos and Soteria Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| setpointmedical.com | 2006 | Santa Clarita, United States | $363.17M | 46 | Implantable neuromodulation devices are developed for inflammatory diseases. | |
| boomerangmedical.com | 2021 | Mountain View, United States | $35M | – | Bioelectronic devices are developed for autoimmune disease treatment. | |
| hippo-dx.com | 2020 | Belgium | $4.67M | 6 | Developer of a medical device to provide an automated test that detects allergies | |
| therakos.com | 1984 | West Chester, United States | – | – | Therakos is focused on photopheresis systems for CTCL treatment. | |
| soteria-medical.com | 2012 | Arnhem, Netherlands | – | – | MRI-guided intervention solutions for prostate biopsies are developed. | |
| theralight.com | 1999 | Lindon, United States | – | – | Provides red light therapy beds to promote cellular health and reduce oxidative stress. | |
| impulsebiomed.com | 2018 | Cape Town, South Africa | – | – | A reloadable adrenaline auto-injector is developed for severe allergic reactions. | |
| surftherapeutics.tcc.mode | 2022 | Austin, United States | – | – | Neuromodulatory technology for autoimmune disorder treatments is developed. |
Detailed competitors of Labseed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Labseed
10 companies that operate in the same segment as Labseed (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Labseed
Labseed was founded in 2009 and raised its 1st funding round 9 years after it was founded.
Labseed is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Labseed is a funded company, having raised a total of $115.35K across 1 funding round to date. The company's 1st funding round was a Seed of $115.35K, raised on Jun 2018.
Labseed was founded in 2009 in Lausanne, Switzerland, within the medical devices sector. Technology aimed at suppressing capsular contraction is developed by the company. MYcoat silicone implants are provided, featuring a treatment surface that lowers fibrotic reactions, reduces rejection of implantable devices, and alleviates associated pain. Operations focus on advancing implant compatibility through these innovations.
Labseed's top competitors include SetPoint Medical, Boomerang Medical and Therakos.
Labseed offers MYcoatâ„¢.
Labseed has 1 investor. Key investors include Venture Kick.